WordNet

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 心不全における心臓再同期療法：適応 cardiac resynchronization therapy in heart failure indications
2. 心不全における心臓再同期療法：植込みおよびその他の考慮事項 cardiac resynchronization therapy in heart failure implantation and other considerations
3. 心房細動における心臓再同期療法 cardiac resynchronization therapy in atrial fibrillation
4. 心臓再同期療法の利益の理論的根拠および機序 rationale for and mechanisms of benefit of cardiac resynchronization therapy
5. 心不全における心臓ペーシングの概要 overview of cardiac pacing in heart failure

Boczar K1, Ząbek A1, Haberka K2, Hardzina M1, Dębski M1, Rydlewska A1, Nowosielska-Ząbek E3, Lelakowski J2, Małecka B2.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University.Adv Clin Exp Med.2016 Jul-Aug;25(1):83-91. doi: 10.17219/acem/42317.
BACKGROUND: Venous stenosis and occlusion in the presence of endocardial leads constitute one of the complications of permanent cardiac pacing either by pacemaker, implantable cardioverter-defibrillator or cardiac resynchronization therapy.OBJECTIVES: The aim of this study was to assess the incidenc
PMID 26935502

X-ray and magnetic resonance imaging fusion for cardiac resynchronization therapy.

Choi J1, Radau P2, Xu R3, Wright GA4.
Medical image analysis.Med Image Anal.2016 Jul;31:98-107. doi: 10.1016/j.media.2016.03.004. Epub 2016 Mar 15.
Cardiac Resynchronization Therapy (CRT) can effectively treat left ventricle (LV) driven Heart Failure (HF). However, 30% of the CRT recipients do not experience symptomatic benefit. Recent studies show that the CRT response rate can reach 95% when the LV pacing lead is placed at an optimal site at
PMID 27025953